Intergroupe Francophone Du Myelome
Clinical trials sponsored by Intergroupe Francophone Du Myelome, explained in plain language.
-
New drug teclistamab tested in patients with Hard-to-Treat myeloma
Disease control OngoingThis study is tracking 200 adults with multiple myeloma whose cancer has returned or stopped responding to treatment. They are receiving teclistamab, a drug that helps the immune system find and destroy myeloma cells. Researchers are measuring how many patients respond to the dru…
Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Pee break: spot urine test could end 24-Hour jug hassle for myeloma patients
Diagnosis OngoingThis study tests whether a single urine sample (spot urine) can detect myeloma proteins as accurately as the standard 24-hour urine collection. Researchers will compare results from 180 multiple myeloma patients starting a new treatment. If the spot test works well, it could make…
Sponsor: Intergroupe Francophone du Myelome • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC